News | February 24, 2024
Briefs: Suven Pharmaceuticals, Remedium Lifecare and Kilitch Drugs India
Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully
Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully
Aarti Drugs has reported total income of Rs. 607.61 crores during the period ended December 31, 2023
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia
Venus Remedies is supplying the drug to many countries like Colombia, Thailand, Tanzania, Morocco, Myanmar, Indonesia, Saudi Arabia, Malaysia, Zimbabwe, Sri Lanka, Pakistan, Kenya, and Botswana
Lack of technology transfer stands out as a formidable barrier
This project will aim to develop a next-generation A3 adenosine receptor drug agonists
Aarti Drugs has reported total income of Rs. 642.22 crores during the period ended September 30, 2023
Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug
NRT offers 50% higher success rate in quitting smoking compared to unassisted attempts
Mankind Pharma's initiative aims to ensure universal access to medicines of international calibre
Subscribe To Our Newsletter & Stay Updated
